The Board of Directors of Santen Pharmaceutical Co., Ltd. has authorized a buyback plan on May 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,628 JPY | +0.90% | +5.00% | +15.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.87% | 3.76B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Santen Pharmaceutical Co., Ltd. authorizes a Buyback Plan.